# BLUEBIRD BIO INC (BLUEXXXX)

> Institutional ownership reported to the SEC as of Q4 2024, from Form 13F filings. Source: https://holderbook.com/stocks/BLUEXXXX/

- Reporting holders: 3
- Reported value: $97.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $94.2K | 10,500 | 0.0% | 3 |
| [Riggs Asset Managment Co. Inc.](https://holderbook.com/funds/1601348-riggs-asset-managment-co-inc/) | $2.8K | 350 | 0.0% | 4 |
| [Raiffeisen Bank International AG](https://holderbook.com/funds/2044885-raiffeisen-bank-international-ag/) | $972 | 112 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2024 | 3 | $97.9K |
| Q3 2024 | 137 | $33.6M |
| Q2 2024 | 149 | $79.3M |
| Q1 2024 | 156 | $141.7M |
| Q4 2023 | 187 | $189.7M |
| Q3 2023 | 168 | $280.2M |
| Q2 2023 | 176 | $311.7M |
| Q1 2023 | 178 | $314.9M |
| Q4 2022 | 183 | $478.2M |
| Q3 2022 | 154 | $422.1M |
| Q2 2022 | 143 | $231.3M |
| Q1 2022 | 165 | $303.8M |